Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
Pozycja w akcjach
#4932
Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally... Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally focusing on the production and distribution of a broad spectrum of pharmaceutical goods. Its product line encompasses various drug forms like oral liquids, injections, capsules, granules, pills, and tablets, as well as traditional Chinese herbal medicines, powders, syrups, and spirits. The company also produces specialized medicinal products, including enzymes, biochemical drugs, and plant-based chemical medicines. In addition to its core pharmaceutical activities, Jilin Aodong diversifies its operations across several other sectors. These include highway construction and toll management, animal husbandry, the creation of specialty chemicals, and the provision of heat and water. The company further engages in the wholesale, retail, and distribution of medicines, packaging design and printing, the manufacturing of medicinal packaging materials, and delivers information consulting and advertising design solutions. Founded in 1957, its corporate headquarters are situated in Dunhua, China.
Cena akcji
$2.48
Kapitalizacja rynkowa
$2.97B
Zmiana (1 dzień)
-0.52%
Zmiana (1 rok)
-13.61%
Kraj
CN
Handel Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Kategoria
Healthcare
EPS dla Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
EPS na dzień June 2026 TTM: $0.41
Według najnowszych raportów finansowych i ceny akcji firmy Jilin Aodong Pharmaceutical Group Co., Ltd., obecny EPS (TTM) wynosi $0.41. Na koniec roku 2023 firma miała EPS w wysokości $0.18, spadek w porównaniu do do EPS z roku 2022, który wynosił $0.23.
Historia EPS dla Jilin Aodong Pharmaceutical Group Co., Ltd. od 2000 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2026 (TTM) | $0.41 | 126.22% |
| 2024 | $0.18 | -1.58% |
| 2023 | $0.18 | -19.29% |
| 2022 | $0.23 | -7.25% |
| 2021 | $0.25 | 8.30% |
| 2020 | $0.23 | 30.38% |
| 2019 | $0.17 | 48.67% |
| 2018 | $0.12 | -52.46% |
| 2017 | $0.25 | 17.77% |
| 2016 | $0.21 | -39.20% |
| 2015 | $0.34 | 74.31% |
| 2014 | $0.20 | 31.33% |
| 2013 | $0.15 | 68.92% |
| 2012 | $0.09 | -67.27% |
| 2011 | $0.27 | 67.37% |
| 2010 | $0.16 | -5.43% |
| 2009 | $0.17 | 58.12% |
| 2008 | $0.11 | -53.71% |
| 2007 | $0.23 | 336.13% |
| 2006 | $0.05 | 355.08% |
| 2005 | $0.01 | 19.19% |
| 2004 | $0.01 | 17.86% |
| 2003 | $0.01 | 31.25% |
| 2002 | $0.01 | 128.57% |
| 2001 | 0.00 | -59.42% |
| 2000 | $0.01 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 36.62% |
IN
|
